| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Gross Margin | 45.36% | 54.11% | — | — | — |
| Operating Margin | -23.45% | -249.60% | — | — | — |
| EBITDA Margin | -22.75% | -244.87% | — | — | — |
| Net Margin | -111.40% | -184.17% | — | — | — |
| Current Ratio | 2.81 | 0.50 | 0.01 | 0.06 | 1.83 |
| Quick Ratio | 2.17 | 0.18 | -0.34 | 0.06 | 1.83 |
| Debt / Equity | 1.57 | -1.04 | — | — | — |
| ROE | -327.12% | 94.20% | 32.16% | 21.21% | 12.42% |
| ROA | -91.58% | -147.62% | -17.20% | -6.61% | -0.47% |
| Asset Turnover | 0.82 | 0.80 | 0.00 | 0.00 | — |
| Book Value / Share | 0.62 | -0.48 | -1.91 | -2.00 | -1.09 |
QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems with low frequency sound waves for detection, diagnosis, and treatment of diseases in the United States and Internationally. The company offers QT Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. It serves patients, medical professionals, and radiologists. The company has a collaboration with Olea Medical S.A.S for the development of QTI Imaging-Olea Viewer; and a strategic partnership with Intelerad Medical Systems Incorporated. QT Imaging Holdings, Inc. was founded in 2012 and is headquartered in Novato, California.